SHILPA MEDICARE share price has zoomed 6% and is presently trading at Rs 853.8.
Meanwhile, the BSE HEALTHCARE index is at 42,509.7 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.8%) and Natco Pharma (up 2.7%).
ASTRAZENECA PHARMA (down 2.9%) and SUVEN PHARMACEUTICALS (down 1.8%) are among the top losers today.
Over the last one year, SHILPA MEDICARE has moved up from Rs 371.5 to Rs 853.8, registering a gain of Rs 482.4 (up 129.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,509.7, registering a gain of 46.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 180.7%), SUVEN PHARMACEUTICALS (up 111.3%) and Glenmark Pharma (up 101.3%).
For Investors: Our Big Prediction
The BSE Sensex is at 77,776.5 (up 0.1%).
The top gainers among the BSE Sensex today are HCl Tech. (up 1.6%) and NTPC (up 0.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 23,586.6 (up 0.1%). Eicher Motor and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,776.5, registering a gain of 12,517.0 points (up 19.2%).
SHILPA MEDICARE net profit grew 519.2% YoY to Rs 176 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 12.4% to Rs 2,925 million during the period as against Rs 2,602 million in April-June 2023.
For the year ended March 2024, SHILPA MEDICARE reported 203.4% increase in net profit to Rs 320 million compared to net loss of Rs 309 million during FY23. Revenue of the company grew 9.7% to Rs 11,516 million during FY24.
The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 162.2.
Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Gains 6%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!